Regulation - Erbitux

Filter

Current filters:

Erbitux

Popular Filters

US FDA approves Erbitux as first-line treatment in KRAS wild-type EGFR

09-07-2012

US drug majors Eli Lilly (NYSE: LLY) and Bristol-Myers Squibb (NYSE: BMY) on Friday received full approval…

Bristol-Myers SquibbEli LillyErbituxNorth AmericaOncologyPharmaceuticalQiagenRegulation

Added indication for Bristol-Myers’ Erbitux approved by FDA

08-11-2011

The US Food and Drug Administration yesterday approved US drug major Bristol-Meyers Squibb’s (NYSE:…

Bristol-Myers SquibbErbituxNorth AmericaOncologyPharmaceuticalRegulation

Erbitux and Gilenya added to Australia’s PBS listing

02-09-2011

More than 400,000 Australians will benefit from new subsidized medicines, effective September 1, as Minister…

Asia-PacificErbituxGilenyaMerck KGaANeurologicalNovartisOncologyPharmaceuticalPricingRegulation

Company Spotlight

ImmunoGen

ImmunoGen

Back to top